Losartan potassium

Losartan potassium is a new drug used for hypertension. It is nonpeptide angiotensin II (AII) receptor antagonist.Losartan potassium is nonpeptide angiotensin II (AII) receptor antagonist and is orally active. It belongs to a new class of drugs

Losartan potassium is a new drug used for hypertension. It is nonpeptide angiotensin II (AII) receptor antagonist.Losartan potassium is nonpeptide angiotensin II (AII) receptor antagonist and is orally active. It belongs to a new class of drugs

Losartan potassium is a new drug used for hypertension. It is nonpeptide angiotensin II (AII) receptor antagonist.Losartan potassium is nonpeptide angiotensin II (AII) receptor antagonist and is orally active. It belongs to a new class of drugs

Losartan potassium is a new drug used for hypertension. It is nonpeptide angiotensin II (AII) receptor antagonist.Losartan potassium is nonpeptide angiotensin II (AII) receptor antagonist and is orally active. It belongs to a new class of drugs

Losartan potassium is a new drug used for hypertension. It is nonpeptide angiotensin II (AII) receptor antagonist.Losartan potassium is nonpeptide angiotensin II (AII) receptor antagonist and is orally active. It belongs to a new class of drugs

Losartan-d3 Carboxylic Acid is a isotopically labeled metabolite of Losartan, a nonpeptide angiotensin II AT1-receptor antagonist. This compound prevents the signal cascade initiated by angiotensin II binding to the receptor, thus inhibiting

Losartan-d4 is a deuterium-labeled version of Losartan, a nonpeptide angiotensin II AT1-receptor antagonist. This compound prevents the signal cascade initiated by angiotensin II binding to the receptor, thus inhibiting vasoconstriction and in turn

LX7101 is a potent inhibitor of LIMK and ROCK2 with IC 50 values of 24, 1.6 and 10 nM for LIMK1 , LIMK2 and ROCK2 , respectively: also inhibits PKA with an IC 50 less than 1 nM.In VitroLX7101 is a dual LIM-kinase and ROCK inhibitor for the treatment

LX7101 is a potent inhibitor of LIMK and ROCK2 with IC 50 values of 24, 1.6 and 10 nM for LIMK1 , LIMK2 and ROCK2 , respectively: also inhibits PKA with an IC 50 less than 1 nM.In VitroLX7101 is a dual LIM-kinase and ROCK inhibitor for the treatment

LX7101 is a potent inhibitor of LIMK and ROCK2 with IC 50 values of 24, 1.6 and 10 nM for LIMK1 , LIMK2 and ROCK2 , respectively: also inhibits PKA with an IC 50 less than 1 nM.In VitroLX7101 is a dual LIM-kinase and ROCK inhibitor for the treatment

LX7101 is a potent inhibitor of LIMK and ROCK2 with IC 50 values of 24, 1.6 and 10 nM for LIMK1 , LIMK2 and ROCK2 , respectively: also inhibits PKA with an IC 50 less than 1 nM.In VitroLX7101 is a dual LIM-kinase and ROCK inhibitor for the treatment

LX7101 is a potent inhibitor of LIMK and ROCK2 with IC 50 values of 24, 1.6 and 10 nM for LIMK1 , LIMK2 and ROCK2 , respectively: also inhibits PKA with an IC 50 less than 1 nM.In VitroLX7101 is a dual LIM-kinase and ROCK inhibitor for the treatment